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Cys-loop receptor binding sites characteristically contain many aromatic amino acids. In nicotinic ACh and 5-HT3 receptors, a Trp
residue forms a cation- interactionwith the agonist, whereas inGABAA receptors, a Tyr performs this role. The glycine receptor binding
site, however, contains predominantly Phe residues.Homologymodels suggest that twoof thesePhe side chains, Phe159 andPhe207, and
possibly a third, Phe63, are positioned such that they could contribute to a cation- interaction with the primary amine of glycine. Here,
we test this hypothesis by incorporation of a series of fluorinated Phe derivatives using unnatural amino acid mutagenesis. The data
reveal a clear correlationbetween theglycineEC50 value and the cation-bindingability of the fluorinatedPhederivatives at position159,
but not at positions 207 or 63, indicating a single cation- interactionbetween glycine andPhe159. Thedata thus provide an anchor point
for locating glycine in its binding site, and demonstrate for the first time a cation- interaction between Phe and a neurotransmitter.
Key words: ligand-gated ion channel; Cys-loop receptor; cation- interaction; unnatural amino acids; nonsense suppression;
neurotransmitter
Introduction
Glycine receptors (GlyRs) mediate fast synaptic inhibition in the
brainstem and spinal cord, and are involved in the generation of
motor rhythm, coordination of reflex circuits, and processing of
a variety of sensory signals, such as pain (Legendre, 2001; Harvey
et al., 2004). GlyR are members of the Cys-loop receptor family
along with GABAA, GABAC, 5-HT3, and nicotinic ACh receptors
(nAChRs) (Le Novere and Changeux, 2001). In these receptors,
five subunits are arranged pseudosymmetrically around a central
ion-conducting pore; each subunit comprises a large N-terminal
ligand-binding domain, and four transmembrane helices that are
connected by loops of varying size (Unwin, 1995;Miyazawa et al.,
2003). Four GlyR  subunits and one GlyR  subunit are known
to date (for review, see Lynch, 2004).
GlyRs are emerging as pharmacological targets; thus, the exact
binding mechanism of agonists and antagonists in GlyRs is of
particular interest (Laube et al., 2002). Previous studies on the
structure of nAChRs and the related acetylcholine binding pro-
teins (AChBPs) (Unwin, 1995; Brejc et al., 2001; Miyazawa et al.,
2003) have confirmed the location of the agonist binding site at
the subunit interface. The binding site is formed by three loops
from one subunit (A–C) and three  strands from the adjacent
subunit (D–F). The binding pockets are rich in aromatic residues,
and previous studies have shown that a cation- interaction be-
tween an aromatic binding site residue and the positively charged
amine on the natural agonist makes a substantial contribution to
agonist binding in nACh, 5-HT3, modulation of locomotion de-
fective 1 (MOD-1), GABAA, andGABAC receptors. Interestingly,
the nature and location of the aromatic residue that interacts with
the cation is not conserved; thus, the residue is Trp on loop B in
nACh and 5-HT3 receptors, Tyr on loop B in GABAC receptors,
Tyr on loop A inGABAA receptors, and Trp on loopC inMOD-1
receptors (Zhong et al., 1998; Beene et al., 2002; Mu et al., 2003;
Lummis et al., 2005; Padgett et al., 2007).
In the GlyR binding site, Phe residues are located at all of the
positions homologous to those involved in cation- interactions
in other Cys-loop receptors (see Table 1). A recent study has
implicated Phe159 and Phe207 in a joint cation- interaction
with the glycine amino groupbased on the results of conventional
mutagenesis and a computational model (Grudzinska et al.,
2005). To date, no cation- interaction identified in a Cys-loop
receptor has involved two contributing amino acid residues. To
determine whether such an interaction exists requires direct ex-
perimental evidence either in the form of high-resolution struc-
tural data (not yet available for GlyRs) or by the incorporation of
unnatural amino acids (Dougherty, 2000; Beene et al., 2003).
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Here, we applied nonsense suppressionmethodology to incorpo-
rate unnatural amino acids, in combination with radioligand
binding studies and computational modeling, to determine
whether one or more Phe residues contributes to a cation- in-
teraction in the GlyR binding site.
Materials andMethods
Mutagenesis and preparation of mRNA and oocytes. The human GlyR 1
subunit cDNA was subcloned into pGEMHE (for oocyte expression)
or pcDNA3.1 (for binding studies). Site-directed mutagenesis was
performed with the QuickChange mutagenesis kit (Stratagene). The
mMessage mMachine kit (Ambion) was used to generate capped mRNA
for oocyte injection. Xenopus laevis (Nasco) oocytes were prepared as
described previously (Pless et al., 2007), and injected with 10 ng of
mRNA. After injection, oocytes were incubated for 24 h at 18°C.
Synthesis of tRNA and dCA amino acids. This was performed as de-
scribed previously (Beene et al., 2004). In brief, unnatural amino
acids (Fig. 1) were chemically synthesized as NVOC (nitrovera-
tryloxycarbonyl)-protected cyanomethyl esters. They were coupled to
the dinucleotide dCA, which was then enzymatically ligated to a 74-mer
THG73 tRNACUA as described previously (Nowak et al., 1998). Directly
before coinjectionwith themRNA, the aminoacyl tRNAwas deprotected
by photolysis (Kearney et al., 1996). In a typical experiment, 10 ng of
mRNA was injected with 25 ng of tRNA-aa in a total volume of 50 nl. In
control experiments,mRNAwas injected alone or together with THG74-
dCA tRNA (with no unnatural amino acid attached).
Characterization of mutant receptors. Peak glycine-induced currents
were recorded from individual oocytes using the OpusXpress voltage-
clamp system (Molecular Devices). All recordings were performed at
22–25°C. Glycine (Sigma) was stored as 1 M aliquots at20°C, diluted in
ND96 [(in mM) 96 NaCl, 2 KCl, 1 MgCl2, 1.8 CaCl2, 5 HEPES, pH 7.4]
before experiments, and delivered to the cells using the computer-
controlled perfusion system of OpusXpress. Glass microelectrodes were
backfilled with 3 M KCl and had resistances between 0.5 and 3 M. All
recordings were performed at a holding potential of 60 mV. The em-
pirical Hill equation, fitted with a nonlinear least squares algorithm, was
used to obtain half-maximal concentrations (EC50) and Hill coefficient
(nH) values for ligand-induced activation (SigmaPlot 9.0, Systat Soft-
ware). Data represent mean SEM.
Radioligand binding.This was undertaken as described previously with
minor modifications (Price and Lummis, 2004). Briefly, transfected hu-
man embryonic kidney 293 cell membranes were incubated for 1 h at
20°C in 0.5 ml of phosphate buffer (50 mM, pH 7.4) containing the
glycine receptor antagonist [ 3H]strychnine at 0.1–40 nM. Nonspecific
binding was determined using 1 mM glycine. Data were analyzed by
iterative curve fitting (Prism version 3.0; GraphPad Software) according
to the equationB (Bmax [L])/(Kd [L]), whereB is bound radioligand,
Bmax is maximum binding at equilibrium, Kd is the equilibrium dissoci-
ation constant, and [L] is the free concentration of radioligand. Data
representmean SEM. Statistical analysis was performedusingANOVA
in conjunction with a Dunnett’s post test.
Modeling. This was performed as described previously (Reeves et al.,
2003; Thompson et al., 2005). Three-dimensional models of the extra-
cellular region of the glycine receptor were built using MODELLER 6,
version 2 (Sali and Blundell, 1993), based on the crystal structure of
AChBP in the agonist-bound state (carbamylcholine, PDB ID; 1uv6).
The model was energy minimized in SYBYL version 6.8 using the AM-
BER force field bymoving side chains alone (Weiner et al., 1984).Models
were viewed using ViewerLite version 5.0. Docking was performed using
GOLD 3.0 (The Cambridge Crystallographic Data Centre, Cambridge,
UK) as described previously (Thompson and Lummis, 2007).
Results
Locating potential cation- interacting residues
An alignment of amino acid residues contributing to the aro-
matic box in Cys-loop receptors reveals that Phe63, Phe99,
Phe159, Tyr202, and Phe207 of the GlyR are all possible candi-
dates to contribute to a cation- interaction (Table 1). Because
Phe99 and Tyr202 could be ruled out on the basis of previous
studies using conventional mutagenesis (see Discussion), only
Phe63, Phe159, and Phe 207 were selected for unnatural amino
acid incorporation. These amino acids were substituted with Phe
analogues with an increasing number of fluorine substituents. A
hydrogen to fluorine substitution in the benzene ring of aromatic
residues is deactivating in the cation- interaction, and the ef-
fects of multiple fluorine substitutions are additive (Zhong et al.,
1998). Thus, a systematic decrease in agonist affinity with in-
creasing fluorination provides compelling evidence for a
cation- interaction. The reluctance to participate in H-bonding
interactions and small steric size further make fluorine an ideal
substituent.
Validation of the nonsense suppression method
Fluorinated Phe residues were incorporated using nonsense sup-
pression. To validate this method, we coinjected themutant mR-
NAs and a suppressor tRNA chemically aminoacylated with Phe.
When coinjected with Phe-tRNA, mutant mRNAs encoding
Phe63TAG, Phe159TAG, Phe207TAG, and Phe159TAG/
Phe207TAG receptors produced functional receptors that re-
sponded to the application of glycine. Maximal currents (Imax)
and EC50 and nH values were similar to each other, and to previ-
ously published results for wild-type (WT) 1 homopentameric
GlyRs expressed in Xenopus oocytes (De Saint Jan et al., 2001).
We thus conclude that the wild-type phenotype is successfully
“rescued” by the nonsense suppression method.
No currents were recorded in response to high (5 mM) con-
Figure 1. Structures of both the natural and unnatural side chains incorporated by the non-
sense suppression method. Carbon numbering as highlighted in the phenylalanine structure.
Table 1. Residues contributing to the aromatic box in the Cys-loop receptor family
Receptor A B C D
nACh Y93 W149 Y190 Y198 W55
5-HT3 E129 W183 F226 Y234 W90
MOD-1 C120 Y180 Y221 W226 F83
GABAC F138 Y198 Y241 Y247 Y102
GABAA Y97 Y157 F200 Y205 F65
Gly F99 F159 Y202 F207 F63
Appropriatebinding segments are labeledaccordingly. Residues inboldhavebeen shown tobe involved in cation-
interactions.
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centrations of glycine from oocytes injected with mutant mRNA
alone or withmutantmRNA and tRNA-dCAwith no amino acid
attached (n  6 each). This indicates that the stop codon at the
position of the mutated phenylalanine, as expected, generates
truncated and consequently nonfunctional receptors. Addition-
ally, this control shows that no endogenous tRNA-aa of the oo-
cyte incorporates a functional amino acid at the mutated sites.
Finally, endogenous synthetases do not seem to reacylate the
tRNAs with naturally occurring amino acids, because we did not
detect currents when mRNA and nonligated tRNA were coin-
jected (n 6).
GlyR Phe63
Introduction of a single fluorine in the 4 position decreased the
EC50 value by a factor of three (Table 2). Introducing a cyano
(CN) group at the same position caused a larger (17-fold) drop in
EC50. Cyano is strongly deactivating in a cation- interaction
(Zhong et al., 1998), and its introduction at a site that contributes
to such an interaction would have the opposite effect, i.e., cause a
substantial increase in EC50. Thus, we can rule out a cation-
interaction at Phe63. Consistent with this reasoning, substitution
with 3,5-F2-Phe or 3,4,5-F3-Phe caused relatively small (twofold
to threefold) changes in EC50 value that produce no consistent
trend when combined with F1-Phe data.We note that 3,5-F2-Phe
and 3,4,5-F3-Phe produced significantly lower maximal currents
(3.2  1.1 and 4.2  0.7 A, respectively), which may explain
the higher EC50 values (De Saint Jan et al., 2001). Previously,
Grudzinska et al. (2005) proposed a cation- interaction be-
tween Phe63 and the guanidinium group of Arg65. The present
results do not support this proposal.
Radioligand binding data reveal Ala substitution results in
nonbinding receptors, whereas Tyr substitution yields receptors
with a Kd similar to wild type (11.2 4.4 nM vs 5.6 1.7 nM in
WT).
GlyR Phe159
Successive addition of fluorines to Phe159 leads to a progressive
decrease in glycine sensitivity (Fig. 2A,B, Table 2), indicating a
cation- interaction at this site, and 4-CN-Phe generates an EC50
value intermediate between those for 3,5-F2-Phe and 3,4,5-F3-
Phe, as could be predicted by their cation- binding ability [de-
termined as described by Mecozzi et al. (1996)]. As in previous
studies with Trp and Tyr, the “fluorination plot” (Zhong et al.,
1998) shown in Figure 2C demonstrates a strong linear correla-
tion between the cation- binding ability and relative log EC50
value (scaled to wild type). Themagnitude and consistency of the
effect show a significant cation- interaction at Phe159.
[3H]strychnine binding supported the hypothesis as the
Phe159Tyrmutant produced values that are not significantly dif-
ferent from wild-type receptors (Kd 3.8 1.1 nM vs 5.6 1.7
nM in WT), whereas Phe159Ala receptors had no specific
binding.
GlyR Phe207
The addition of a single fluorine at Phe207 (F1-Phe) resulted in
no change in the glycine EC50 value (Table 2). However, the
addition of larger groups (4-Me-Phe, 4-OMe-Phe, and 4-CN-
Phe) yielded EC50 values 10- to 30-fold higher. 3,5-F2Phe and
3,4,5-F3Phe yielded large increases in EC50 (500-fold and 100-
fold, respectively). Together, these results are not consistent with
a cation- interaction involving Phe207, because there is no ap-
parent correlation with the cation- binding ability of the incor-
porated unnatural amino acid, and any substituent added to the
benzene ring increases the EC50.
Additional evidence against a cation- interaction at Phe 207
stems from results with the Phe159TAG/Phe207TAG double-
mutant receptor. If Phe159 and Phe207 both contribute to a
cation- interaction with the glycine amine group, a large in-
crease in EC50 would be expected when both interactions are
simultaneously weakened. This was, however, not the case. Re-
ceptors containing the Phe159TAG/Phe207TAG mutation dis-
played robust expression and electrophysiological properties
similar to those of wild-type receptors when coinjected with Phe-
tRNA (Fig. 3). Addition of a single fluorine (4-F1-Phe) to both
sites produced receptors with only a small decrease in glycine
sensitivity (Table 2). The Phe159TAG/Phe207TAG double mu-
tant did not produce a functional receptor with 3,5-F2Phe-tRNA.
However, introduction of a cyano group (4-CN-Phe) yielded re-
ceptors displaying a greatly reduced glycine sensitivity, with an
EC50 value in excess of 400 mM (Fig. 3).
Phe207Ala abolished [3H] strychnine binding, and
Phe207Tyr yielded values for binding significantly higher than
that of WT receptors (Kd 71.9 4.5 nM). Given that the same
mutation had no measurable effect on the glycine EC50 value
(data not shown), this suggests that the shape of the binding site
around Phe207 is more critical for strychnine than for glycine
binding. Additionally, because of the very similar cation- bind-
ing abilities of Phe and Tyr, our data argue against a cation-
interaction between the protonated N19 of strychnine, as sug-
gested by Grudzinska et al. (2005).
Discussion
Here, we show that there is a cation- interactionwith Phe159 on
loop B in the GlyR. This is the sixth Cys-loop receptor for which
a linear fluorination plot has revealed a single cation- interac-
tion. These data show the most common location for a cation-
interaction is an aromatic on loop B (Trp 149 of the nAChR, Trp
183 of the 5-HT3R, Tyr 198 of the GABAC receptor, and Phe159
of the GlyR). However, cation- interactions with residues on
loopA (Tyr97 in theGABAA receptor) and loopC (Trp226 on the
MOD-1 receptor) have also been observed, indicating neither the
location nor the identity of the aromatic residue that participates
Table 2. Dose–response data for GlyR with unnatural amino acids at positions 63,
159, 207, and the 159/207 double-mutant construct
Mutant EC50 (M) nH Imax (mA) n
63-Phe (WT) 113 4 2.6 0.2 8.6 1.4 7
63-F1-Phe 34.5 0.1* 2.8 0.1 8.9 0.7 7
63-F2-Phe 210 9* 2.1 0.2 3.2 1.1* 3
63-CN-Phe 6.5 0.4* 2.7 0.4 7.9 1.5 5
63-F3-Phe 348 19* 1.8 0.2 4.2 0.7* 5
159-Phe (WT) 109 2 2.8 0.2 7.4 0.6 5
159-F1-Phe 288 6* 3.1 0.2 6.8 1.1 4
159-F2-Phe 11000 200* 2.0 0.1* 7.7 0.6 6
159-CN-Phe 46100 1400* 1.9 0.1* 9.2 1.2 9
159-F3-Phe 103000 2700* 2.3 0.1 5.6 0.6 7
207-Phe (WT) 114 3 2.2 0.1 10.8 1.1 4
207-ME-Phe 1020 20* 2.2 0.1 10.1 3.3 4
207-O-ME-Phe 2520 140* 2.2 0.3 10.3 0.4 4
207-F1-Phe 151 4 2.4 0.1 9.5 2.6 4
207-F2-Phe 56700 600* 2.4 0.1 8.1 0.2* 5
207-CN-Phe 3910 60* 2.6 0.1 9.7 1.4 4
207-F3-Phe 13500 700* 2.4 0.2 8.4 1.2 8
159,207-Phe (WT) 131 1 2.7 0.1 9.3 1.3 18
159,207-F1-Phe 287 10* 2.6 0.3 7.7 1.7 13
Data are mean SEM.
*p 0.05, significantly different fromWT rescue (Student’s t test).
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in this interaction is conserved throughout
this receptor family. The fluorination plots
of all of these receptors (Fig. 2D) show that
there is some variation in the slopes of the
plots. ACh has the shallowest slope, which
may be because the quaternary ammo-
nium [RN(CH3)3
] of ACh presents a less
focused positive charge than the primary
ammonium (RNH3
) of 5-HT3, GABA,
and glycine; the strong electrostatic com-
ponent of the cation- interaction means
that a more focused charge should pro-
duce a stronger effect.
Previous studies in the GlyR, based
mostly on modeling data, suggested that a
cation- interaction involving both
Phe159 and Tyr207may exist, although no
direct evidence was shown (Grudzinska et
al., 2005); these residues, and also Phe63,
were all possible candidates for such an in-
teraction. There are other aromatic resi-
dues in the binding pocket (Tyr161,
Phe99, Phe100, and Tyr202), but previous
data suggest that these are unlikely to con-
tribute to a cation- interaction. For
Tyr161, the nonaromatic Tyr161Ala mu-
tation results in only a moderate (10-
fold) loss in glycine sensitivity (Vanden-
berg et al., 1992b; Yang et al., 2007), and
similarly, Ala substitutions of Phe99 and
Phe100 in loop B result in only small
changes of the EC50 value (Vafa et al.,
1999). For Tyr202, it has been convinc-
ingly demonstrated that the hydroxyl
group of Tyr202 and not its aromatic char-
acter is crucial for agonist binding (Rajen-
dra et al., 1995).
The cationicmoiety contributing to the
cation- interaction at Phe159 could, in
theory, originate from a positively charged
amino acid such as Arg65, Arg 131,
Lys200, or Lys206, which are all in close
proximity. Arg65 is proposed to make
contact with the carboxylate of glycine, lo-
cating this residue at the opposite end of
the binding pocket (Grudzinska et al.,
2005), whereas neutralizing Arg131 (in
Arg131Ala mutant receptors), Lys200
(Lys200Ala) or Lys206 (Lys206Ala) shows
only amoderate or no effect on the glycine
EC50 value (Vandenberg et al., 1992a; Yang
et al., 2007). We thus conclude that
Phe159 forms a direct cation- interaction
with the positive amine of glycine.
Our model of glycine docked into the
binding site (Fig. 4) is consistent with the experimental data in
showing the potential for a cation- interaction between glycine
and Phe159, and is also consistent with an interaction of the
carboxylate of glycine and Arg65 as discussed above. As in the
previous model used by Grudzinska et al. (2005), however,
the location of the positive amine in ourmodel is not inconsistent
with a cation- interaction at Phe207. This finding therefore
emphasizes the importance of experimental data to support
modeling and docking studies. Our data with Phe207 do not
support a cation- interaction with this residue. We also per-
formed experiments with double-mutant receptors (Phe159/
Phe207) to confirm this finding. The measured EC50 value of
300 M for receptors with F-Phe at both of these positions is
close to the calculated value of380 M that would be expected
if the EC50 value were simply the product of the two individual
mutations. Substitution with 4-CN-Phe, although not 3,5-F2-
Figure2. GlyR responses fromPhe159mutant receptors yield a linear fluorinationplot.A, Current traces recorded fromoocytes
coinjectedwith GlyR F159TAGmRNA and Phe tRNA (i.e.,WT receptors; top) or GlyR Phe159TAGmRNA and F3-Phe tRNA (bottom).
Horizontal bars indicate the duration of glycine application.B, Glycine-induced current dose–response curves.C, Fluorination plot
of theGlyRPhe159mutants; logEC50 value (basedondata in Table2)normalized to thewild-type logEC50 value. Linear fit resulted
in y  5.84–0.22 (r  0.99). D, Fluorination plots comparing the cation- interactions of Gly, nACh, GABAA, and 5-HT3
receptors. The x-axis is offset so the nonfluorinated parent side chain equals 0 (Trp for nAChR, and 5-HT3 and Phe for GABAAR and
GlyR, respectively). Note that the value for CN-Phe is omitted in the gradient for the GlyR (the linear fit is virtually unchanged: y
5.58–0.22; r0.99). Thegradients forMOD-1andGABACRare almost identical to those of the5-HT3Rand theGlyR, respectively,
and are omitted for clarity.
Figure 3. Phe159TAG/Phe207TAG double-mutant receptor responses. A, Current recordings from Phe159TAG/Phe207TAG
mRNA coinjected with Phe tRNA (top) or CN-Phe tRNA (bottom). Horizontal bars indicate the duration of glycine application. B,
Glycine-induced current dose–response relationships and fits to theHill equation for GlyRPhe159TAG/Phe207TAGmRNA injected
with different tRNAs. Note that the dashed line for CN-Phe indicates that the EC50 value cannot be determined accurately because
of the high glycine concentrations required.
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Phe, at both sites resulted in functional receptors, although the
glycine EC50 value (400 mM) could not be determined (Fig. 3).
However, these data are consistent with the calculated EC50 value
of1.5 M glycine for a multiplicative effect of the EC50 values for
the single mutations Phe159CN-Phe and Phe207CN-Phe. To-
gether, the results from both the Phe207TAG single mutant and
the Phe159TAG/Phe207TAG double mutant support the pres-
ence of only one cation- interaction in the GlyR binding site,
namely that at position 159.
The current data rule out a cation- interaction at position
207, although the presence of an aromatic seems to be imperative
for proper receptor function, as demonstrated by the present
study and previous work (Grudzinska et al., 2005). Because gly-
cine is a smaller molecule than the ligands that activate other
Cys-loop neurotransmitters, the GlyR binding site may be more
compact than any of the other aromatic boxes examined thus far,
which could make it more sensitive to incorporation of Phe ana-
logues that have a steric effect. This proposal is supported by the
fact that the glycine EC50 value is affected by the bulk of the group
attached to the 4 position of Phe207. The results also suggest that
groups added to the Phe207 benzene ring exert an even stronger
effect when added to the 3 and/or 5 position.
Thus, in conclusion, our data show a strong correlation be-
tween receptor function and the cation- binding abilities of Phe
analogues when they are incorporated at position 159, indicating
a cation- interaction between the primary amine of glycine and
the side chain of Phe at this location. Our experimental data rule
out cation- interactions at Phe63 and Phe207. Similar to the
agonist glycine, the competitive antagonist strychnine requires
the presence of aromatic side chains at positions 63, 159, and 207.
Importantly, strychnine appears more sensitive to alterations at
position 207 than glycine, providing insight into the molecular
differences in the recognition of agonists and antagonists by neu-
rotransmitter receptors. An accurate knowledge of the correct
orientation of the neurotransmitter and the nature of the inter-
actions involved in the binding event is important for under-
standing its mechanism of action. Because there is now an in-
creasing number of models of the binding sites of Cys-loop
receptors available, this information will help to delineate
receptor-specific differences (as well as similarities) within this
neurotransmitter receptor family and thus provide the basis for
rational drug design in the future.
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